ESR1 and breast cancer: A high level of MOF in ERα− BC cells resulted in the instability of ER protein due to HSP90 hyperacetylation and loss of chaperone function, whereas MOF inhibition would abrogate the foregoing effects to restore ERα abundance and partial sensitivity to endocrine therapy.